Matches in Wikidata for { <http://www.wikidata.org/entity/Q70696460> ?p ?o ?g. }
Showing items 1 to 44 of
44
with 100 items per page.
- Q70696460 description "artículu científicu espublizáu n'ochobre de 1984" @default.
- Q70696460 description "im Oktober 1984 veröffentlichter wissenschaftlicher Artikel" @default.
- Q70696460 description "scientific article published on 01 October 1984" @default.
- Q70696460 description "wetenschappelijk artikel" @default.
- Q70696460 description "наукова стаття, опублікована в жовтні 1984" @default.
- Q70696460 name "A phase II study of the combination, 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and N-(phosphonacetyl)-L-aspartate (PALA), in patients with advanced large bowel cancer" @default.
- Q70696460 name "A phase II study of the combination, 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and N-(phosphonacetyl)-L-aspartate (PALA), in patients with advanced large bowel cancer" @default.
- Q70696460 type Item @default.
- Q70696460 label "A phase II study of the combination, 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and N-(phosphonacetyl)-L-aspartate (PALA), in patients with advanced large bowel cancer" @default.
- Q70696460 label "A phase II study of the combination, 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and N-(phosphonacetyl)-L-aspartate (PALA), in patients with advanced large bowel cancer" @default.
- Q70696460 prefLabel "A phase II study of the combination, 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and N-(phosphonacetyl)-L-aspartate (PALA), in patients with advanced large bowel cancer" @default.
- Q70696460 prefLabel "A phase II study of the combination, 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and N-(phosphonacetyl)-L-aspartate (PALA), in patients with advanced large bowel cancer" @default.
- Q70696460 P1433 Q70696460-5E21E207-2187-4110-A0E8-1C14715CA692 @default.
- Q70696460 P1476 Q70696460-32ADE12B-7C12-4198-849E-AC0F24BAC500 @default.
- Q70696460 P2093 Q70696460-193D3FB7-D64A-4746-AE3D-9D3A079CF0C7 @default.
- Q70696460 P2093 Q70696460-1B88DF05-DF2C-4957-A3B5-6BE81E4B8C86 @default.
- Q70696460 P2093 Q70696460-3BB4BE66-E868-428F-86F3-3009E3C4F04E @default.
- Q70696460 P2093 Q70696460-A2C02F98-9576-40DA-AD26-C3C52196DFB7 @default.
- Q70696460 P2093 Q70696460-E8631417-8C37-428E-8150-86867305EF6D @default.
- Q70696460 P304 Q70696460-C9603F4D-3B8A-49DD-AF1D-452BC914CF52 @default.
- Q70696460 P31 Q70696460-6260F2EF-B996-4E35-AEA6-A716EC2DE30D @default.
- Q70696460 P356 Q70696460-DD94E536-6E72-4293-9219-B1BDFF27F521 @default.
- Q70696460 P433 Q70696460-81012E51-9607-460B-AD69-971538927D67 @default.
- Q70696460 P478 Q70696460-D768FA04-C48A-44F0-B61C-7D83D3D91DB5 @default.
- Q70696460 P577 Q70696460-2CB5847D-9CD0-4144-8C85-3F484E4721EA @default.
- Q70696460 P698 Q70696460-B5143661-AB59-4B55-99EE-41ED0E81CCEA @default.
- Q70696460 P921 Q70696460-EF4301F7-1C14-4146-8E9F-7B21CD151E98 @default.
- Q70696460 P356 00000421-198410000-00025 @default.
- Q70696460 P698 6507373 @default.
- Q70696460 P1433 Q2886177 @default.
- Q70696460 P1476 "A phase II study of the combination, 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and N-(phosphonacetyl)-L-aspartate (PALA), in patients with advanced large bowel cancer" @default.
- Q70696460 P2093 "A J Schutt" @default.
- Q70696460 P2093 "C G Moertel" @default.
- Q70696460 P2093 "J Rubin" @default.
- Q70696460 P2093 "M A Gertz" @default.
- Q70696460 P2093 "M J O'Connell" @default.
- Q70696460 P304 "523-525" @default.
- Q70696460 P31 Q13442814 @default.
- Q70696460 P356 "10.1097/00000421-198410000-00025" @default.
- Q70696460 P433 "5" @default.
- Q70696460 P478 "7" @default.
- Q70696460 P577 "1984-10-01T00:00:00Z" @default.
- Q70696460 P698 "6507373" @default.
- Q70696460 P921 Q25493920 @default.